Evaluation of serum and fecal parameters in cats with low-grade intestinal T-cell lymphoma (LGITCL)

Alessandra Gavazza1, Sara Mangiaterra1, Livio Galosi1

  • 1School of Biosciences and Veterinary Medicine, University of Camerino, 62024 Matelica, MC, Italy.

PubMed

Insights

Low-grade intestinal T-cell lymphoma (LGITCL) in cats is linked to altered gut bacteria and lower protein and cholesterol levels. These changes may indicate a protein-losing enteropathy and a modified gastrointestinal environment.

Area of Science:

  • Veterinary Medicine
  • Gastroenterology
  • Oncology

Background:

  • Low-grade intestinal T-cell lymphoma (LGITCL) is the most common intestinal neoplasia in cats.
  • While genetics and environment contribute, chronic inflammation plays a key role in LGITCL pathogenesis.
  • Understanding diagnostic and prognostic markers is crucial for managing feline LGITCL.

Purpose of the Study:

  • To investigate potential diagnostic and prognostic parameters in feline LGITCL.
  • To evaluate fecal bacterial populations and serum biomarkers in cats with LGITCL.
  • To compare these parameters between cats with LGITCL and healthy controls.

Main Methods:

  • Histologically diagnosed LGITCL cases (n=12) and healthy controls (n=12) were studied.
  • Fecal bacterial populations were analyzed.
  • Serum biomarkers including SAA, citrulline, total protein, amylase, lipase, DGGR lipase, cholesterol, LPS, and zonulin were measured.

Main Results:

  • Fecal analysis revealed decreased Faecalibacterium spp. and Clostridium hiranonis, with increased E. coli, Streptococcus spp., and Turicibacter spp. in the LGITCL group.
  • Serological tests showed significantly lower total proteins, amylase, and cholesterol in cats with LGITCL compared to controls.
  • These findings suggest a potential link between LGITCL and alterations in the feline gastrointestinal environment.

Conclusions:

  • Feline LGITCL may be associated with dysbiosis and a protein-losing enteropathy.
  • Changes in specific fecal bacteria and serum biomarkers could serve as diagnostic or prognostic indicators.
  • Further research with larger patient cohorts is warranted to validate these findings and explore other potential biomarkers.

Related Concept Videos